Boehringer Ingelheim Investigational Site

Panama City, Florida

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Hypertension, Parkinson Disease, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Dose Finding Study in COPD — Completed
• A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients — Completed
• Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma — Completed
• A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) — Completed